Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024

Rhea-AI Summary

Medpace Holdings will announce its Q2 2024 financial results post-market on July 22, 2024.

A conference call to discuss the results is scheduled for July 23, 2024, at 9:00 a.m. ET.

Participants must register in advance via a provided link, and step-by-step access details will be sent by email.

The call can also be accessed through a webcast on Medpace's investor site, where a replay and supplemental slide presentation will be available post-call.

Medpace is traded under the ticker MEDP on Nasdaq.

CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2024 financial results after the market close on Monday, July 22, 2024. The Company will host a conference call the following morning, Tuesday, July 23, 2024, at 9:00 a.m. ET to discuss these results.

To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,800 people across 42 countries as of March 31, 2024.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240626082979/en/

Investor Contact:

Lauren Morris

513.579.9911 x11994

l.morris@medpace.com

Media Contact:

Julie Hopkins

513.579.9911 x12627

j.hopkins@medpace.com

Source: Medpace Holdings, Inc.

FAQ

When will Medpace report its Q2 2024 financial results?

Medpace will report its Q2 2024 financial results after the market closes on July 22, 2024.

How can I join Medpace's Q2 2024 financial results conference call?

Participants must register in advance using the provided link. Upon registration, an email with call access details, including a dial-in number and unique PIN, will be sent.

What time is Medpace's conference call for discussing Q2 2024 financial results?

The conference call is scheduled for July 23, 2024, at 9:00 a.m. ET.

Where can I access the webcast for Medpace's Q2 2024 financial results call?

The webcast can be accessed through the 'Investors' section of Medpace’s website at investor.medpace.com.

What ticker symbol does Medpace trade under?

Medpace trades under the ticker symbol MEDP on Nasdaq.

Will there be a replay available for Medpace's Q2 2024 financial results call?

Yes, a webcast replay will be available approximately one hour after the end of the call on Medpace's investor site.